1. Home
  2. ZLAB vs VCTR Comparison

ZLAB vs VCTR Comparison

Compare ZLAB & VCTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • VCTR
  • Stock Information
  • Founded
  • ZLAB 2013
  • VCTR 2013
  • Country
  • ZLAB China
  • VCTR United States
  • Employees
  • ZLAB N/A
  • VCTR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • VCTR Investment Managers
  • Sector
  • ZLAB Health Care
  • VCTR Finance
  • Exchange
  • ZLAB Nasdaq
  • VCTR Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • VCTR 3.9B
  • IPO Year
  • ZLAB 2017
  • VCTR 2018
  • Fundamental
  • Price
  • ZLAB $29.24
  • VCTR $59.14
  • Analyst Decision
  • ZLAB Buy
  • VCTR Buy
  • Analyst Count
  • ZLAB 4
  • VCTR 10
  • Target Price
  • ZLAB $47.37
  • VCTR $68.80
  • AVG Volume (30 Days)
  • ZLAB 1.2M
  • VCTR 284.4K
  • Earning Date
  • ZLAB 05-08-2025
  • VCTR 05-08-2025
  • Dividend Yield
  • ZLAB N/A
  • VCTR 2.86%
  • EPS Growth
  • ZLAB N/A
  • VCTR 38.50
  • EPS
  • ZLAB N/A
  • VCTR 4.50
  • Revenue
  • ZLAB $418,326,000.00
  • VCTR $897,222,000.00
  • Revenue This Year
  • ZLAB $44.43
  • VCTR $38.78
  • Revenue Next Year
  • ZLAB $48.68
  • VCTR $15.08
  • P/E Ratio
  • ZLAB N/A
  • VCTR $13.13
  • Revenue Growth
  • ZLAB 43.72
  • VCTR 7.38
  • 52 Week Low
  • ZLAB $15.65
  • VCTR $43.82
  • 52 Week High
  • ZLAB $39.77
  • VCTR $73.42
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 42.71
  • VCTR 53.71
  • Support Level
  • ZLAB $27.61
  • VCTR $58.01
  • Resistance Level
  • ZLAB $32.02
  • VCTR $61.03
  • Average True Range (ATR)
  • ZLAB 1.23
  • VCTR 1.86
  • MACD
  • ZLAB -0.18
  • VCTR 0.38
  • Stochastic Oscillator
  • ZLAB 23.41
  • VCTR 67.16

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About VCTR Victory Capital Holdings Inc.

Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.

Share on Social Networks: